.jpeg)
Where is Deferasirox dispersible tablets produced?
Deferasirox dispersible tablets (Deferasirox) produced by companies such as Novartis under the brand nameExjade is an oral iron chelator. Its primary use is to reduce chronic iron overload in patients receiving chronic transfusions for conditions such as beta-thalassemia and other chronic anemias. It is the first oral drug approved for this purpose in the United States. It was approved by the U.S. Food and Drug Administration (FDA) in November 2005 and is included in the World Health Organization's Essential Medicines List. The active substance in Deferasirox dispersible tablets works by attaching to iron in the body so that it can be excreted (removed from the body) in the feces.
[ 免责声明 ] 本页面内容来自公开渠道（如FDA官网、Drugs官网、原研药厂官网等），仅供持有医疗专业资质的人员用于医学药学研究参考，不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市，不适用于中国境内销售和使用。如需治疗，请咨询正规医疗机构。本站不提供药品销售或代购服务。
